Prolonged follow-up confirms that all-trans retinoic acid followed by chemotherapy reduces the risk of relapse in newly diagnosed acute promyelocytic leukemia. The French APL Group.
Fenaux
P
P
Wattel
E
E
Archimbaud
E
E
Sanz
M
M
Hecquet
B
B
Fegueux
N
N
Guerci
A
A
Link
H
H
Fey
M
M
Castaigne
S
S
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005500:Follow-Up Studies; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000188:drug therapy*; D008875:Middle Aged; D010865:Pilot Projects; D012008:Recurrence; D014212:Tretinoin / Q000627:therapeutic use*
D014212:Tretinoin